Skip to main content

Advertisement

SpringerLink
Log in

FK 506: a novel immunosuppressant for treatment of autoimmune disease

Rationale and preliminary clinical experience at the University of Pittsburgh

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abu-Elmagd K, Jegasothy BV, Ackerman CD, Thomson AW, Rilo H, Nikolaidis N, et al. (1991) Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 23:3328

    Google Scholar 

  2. Arita C, Hotokebuchi T, Miyahara H, Arai K, Sugioka Y, Takagishi K, Kaibara N (1990) Inhibition by FK 506 of established lesions of collagen-induced arthritis in rats. Clin Exp Immunol 832:456

    Google Scholar 

  3. Baker BS, Fry L (1992) The immunology of psoriasis. Br J Dermatol 126:1

    Google Scholar 

  4. Canadian-European Randomized Control Trial Group (1988) Cyclosporin-induced remission of IDDM after early intervention. Association of 1 year of cyclosporin treatment with enhanced insulin secretion. Diabetes 37:1574

    Google Scholar 

  5. Carroll PB, Strasser S, Alejandro R (1991) The effect of FK 506 on cyclophosphamide-induced diabetes in the NOD mouse model. Transplant Proc 23:3348

    Google Scholar 

  6. Castano L, Eisenbarth GL (1990) Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647

    Google Scholar 

  7. Clark G, Williams DG (1992) Immunology of minimal-change nephropathy. In: Pusey P (ed) Immunology of renal diseases. Kluwer, Boston, pp 161

    Google Scholar 

  8. Dohi K, Iwano M, Muraguchi A, Horii Y, et al. (1991) The prognostic significance of urinary interleukin 6 in IgA nephropathy. Clin Nephrol 33:1

    Google Scholar 

  9. Firestein GS (1992) Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis. Curr Opin Rheumatol 4:348

    Google Scholar 

  10. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR (1991) Nuclear association of a T-cell transcription factor blocked by FK 506 and cyclosporin A. Nature 352:803

    Google Scholar 

  11. Forrester JV (1991) Uveitis: pathogenesis. Lancet 338:1498

    Google Scholar 

  12. Fujino Y, Mochizuki M, Raber J, Kotake S, Gery I, Nussenblatt RB (1990) FK 506 treatment of S-antigen induced uveitis in primates. Invest Ophthalmol Vis Sci 31:61

    Google Scholar 

  13. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, et al (1991) Adverse effects associated with the use of FK 506. Transplant Proc 23:3105

    Google Scholar 

  14. Hanawa H, Kodama M, Zhang S, Izumi T, Shibata A (1992) An immunosuppressant compound, FK 506, prevents the progression of autoimmune myocarditis in rats. Clin Immunol Immunopathol 62:321

    Google Scholar 

  15. Hara S, Fukatsu A, Suzuki N, Sakamoto N, Matsuo S (1990) The effects of a new immunosuppressive agent, FK 506, on the glomerular injury in rats with accelerated nephrotoxic serum glomerulonephritis. Clin Immunol Immunopathol 57:351

    Google Scholar 

  16. Hintzen RQ, Polman CH, Lucas CJ, van Lier RAW (1992) Multiple sclerosis: immunological findings and possible implications for therapy. J Neuroimmunol 39:1

    Google Scholar 

  17. Hiraoka Y, Kishimoto C, Kurokawa M, Ochiai H, Sasayama S (1992) The effects of FK 506, a novel and potent immunosuppressant, upon murine coxsackievirus B3 myocarditis. J Pharmacol Exp Ther 260:1386

    Google Scholar 

  18. Hisanaga S, Kawagoe H, Yamamoto Y, Kuroki N, Fujimoto S, Tanaka K, Kurokawa M (1990) Nephrotic syndrome associated with recombinant interleukin-2. Nephron 54:277

    Google Scholar 

  19. Inamura N, Hashimoto M, Nakahara K, Nakajima Y, Nishio M, Aoki H, Yamaguchi I, Kohsaka M (1988) Immunosuppressive effect of FK 506 on experimental allergic encephalomyelitis in rats. Int J Immunopharmacol 10:991

    Google Scholar 

  20. Inamura N, Hashimoto M, Nakahara K, Aoki H, Damaguchi I, Kohsaka M (1988) Immunosuppressive effect of FK 506 on collagen-induced arthritis in rats. Clin Immunol Immunopathol 46:82

    Google Scholar 

  21. Jegasothy BV, Ackerman CD, Todo S, Fung JJ, Abu-Elmagd K, Starzl TE (1992) Tacrolimus (FK 506) — A new therapeutic agent for severe psoriasis. Arch Dermatol 128:781

    Google Scholar 

  22. Jordan SC, Querfeld U, Toyoda M, Prehn J (1990) Serum interleukin-2 levels in a patient with focal segmentai glomerulosclerosis. Relationship to clinical course and cyclosporin A therapy. Pediatr Nephrol 4:166

    Google Scholar 

  23. Kawashima H, Fujino Y, Mochizuki M (1988) Effects of a new immunusuppressive agent, FK 506, on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci 23:1265

    Google Scholar 

  24. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) FK 506, a novel immunosuppressant isolated from a Streptomyces. II. Fermentation, isolation and physiochemical and biological characteristics. J Antibiot (Tokyo) 40:1249

    Google Scholar 

  25. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H, Ochiai T (1987) FK 506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK 506 in vitro. J Antibiot (Tokyo) 40:1256

    Google Scholar 

  26. Krawitt EL, Wiesner RH (1991) Autoimmune liver diseases. Raven Press, New York

    Google Scholar 

  27. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK 506 complexes. Cell 66:807

    Google Scholar 

  28. Matsukawa W, Hara S, Yoshida F, Suzuki N, Fukatsu A, Yuzawa Y, Sakamoto N, Matsuo S (1992) Effects of a new immunosuppressive agent, FK 506, in rats with active Heymann nephritis. J Lab Clin Med 119:116

    Google Scholar 

  29. McCauley J, Shapiro R, Scantlebury V, Gilboa N, et al (1991) FK 506 in the management of transplant related nephrotic syndrome and steroid resistant nephrotic syndrome. Transplant Proc 23:3354

    Google Scholar 

  30. McCauley J, Shapiro R, Ellis D, Igdal H, eaet al (1993) A pilot trial of FK 506 in the management of steroid resistant nephrotic syndrome. Nephrol Dial Transplant (in press)

  31. Meingassner JG, Stutz A (1992) Immunosuppressive macrolides of the type FK 506:a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98:851

    Google Scholar 

  32. Miyagawa J, Yamamoto K, Hanafusa T, Itoh N, Nakagawa C, Otsuka A, Katsura H, Yamagata K, Miyazaki A, Kono N, Tarui S (1990) Preventive effect of a new immunosuppressant FK 506 on insulinitis and diabetes in non-obese diabetic mice. Diabetologia 33:503

    Google Scholar 

  33. Mochizuki M, Masuda K, Sakane T, Inaba G, Ito K, Kogure M, et al (1991) A multi-centre clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Transplant Proc 23:3343

    Google Scholar 

  34. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145

    Google Scholar 

  35. Murase N, Lieberman I, Nalesnik M, Mintz D, Todo S, Drash AL, Starzl TE (1990) FK 506 prevents spontaneous diabetes in the BB rat. Lancet 11:373

    Google Scholar 

  36. Nicoletti F, Meroni PL, Barcellini W, Grasso S, Borghi MO, Lunetta M, Di Marco R, Stefani S, Mughini L (1991) FK 506 prevents diabetes in diabetes-prone BB/Wor rats. Immunopharmacology 13:1027

    Google Scholar 

  37. Ohno I, Gomi H, Matsuda H, Nakano H, Matsumoto H, Kodama K (1991) Soluble IL-2 receptor in patients with primary nephrotic syndrome. Nippon Jinzo Gakkai Shi 33:489

    Google Scholar 

  38. Okuba Y, Tsukada Y, Maezawa A, Ono K, Ydano S, Naruse T (1990) FK 506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis. Clin Exp Immunol 82:450

    Google Scholar 

  39. Roitt IM, Hutchings PR, Dawe KI, Sumar N, Bodman KB, Cooke A (1992) The forces driving autoimmune disease. J Autoimmun 5 [Suppl A]: 11

    Google Scholar 

  40. Rose NR (1988) Current concepts of autoimmune disease. In: Kahan BD (eds) Cyclosporine, Applications in autoimmune diseases. Grune & Stratton, Philadelphia, pp 3–10

    Google Scholar 

  41. Sawada S, Suzuki G, Kawase Y, Takaku F (1987) Novel immunosuppressive agent, FK 506. In vitro effects on the cloned T cell activation. J Immunol 139:1797

    Google Scholar 

  42. Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK 506. Immunol Today 13:136

    Google Scholar 

  43. Sigal NH, Dumont FJ (1992) Cyclosporin A, FK 506, and rapamycin: pharmacologie probes of lymphocyte signal transduction. Annu Rev Immunol 10:519

    Google Scholar 

  44. Starzl TE, Fung J, Venkataramanan R, Todo S, Demetris AJ, Jain A (1989) FK 506 for liver, kidney and pancreas transplantation. Lancet II:1000

    Google Scholar 

  45. Starzl TE, Todo S, Fung JJ, Groth C (eds) (1990) FK 506. A potential breakthrough in immunosuppression - clinical implications. Transplant Proc 22:5

  46. Starzl TE, Thomson AW, Todo S, Fung JJ, Starzl TE (eds) (1991) Proceedings of the first international congress on FK 506. Transplant Proc 23:2709

  47. Takabayashi K, Koike T, Kurasawa K, Matsumura R, Sato T, Tomioka H, Ito I, Yoshiki T, Yoshida S (1989) Effect of FK 506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin Immunol Immunopathol 51:110

    Google Scholar 

  48. Takagishi K, Yamamoto M, Nishimura A, Yamasaki G, Kanazawa N, Hotekebuchi T, Kaibara N (1989) Effects of FK 506 on collagen arthritis in mice. Transplant Proc 21:1053

    Google Scholar 

  49. Tamura K, Woo J, Murase N, Carrieri G, Nalesnik MA, Thomson AW (1993) Suppression of autoimmune thyroid disease by FK, 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. Clin Exp Immunol 91:368

    Google Scholar 

  50. Thomson AW (1989) FK 506, How much potential? Immunol Today 10:6–9

    Google Scholar 

  51. Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI (1989) The immunosuppressant FK 506 selectively inhibits expression of early T cell activation genes. J Immunol 143:718

    Google Scholar 

  52. von Graffenried B, Friend D, Shand N, Scheiss W, Timonen P (1989) Cyclosporin A (Sandimmun) in autoimmune diseases. In: Thomson AW (ed) Cyclosporin. Mode of action and clinical application. Kluwer, Boston, pp 213–251

    Google Scholar 

  53. Wang SC, Zeevi A, Tweardy DJ, Jordan ML, Simmons RL (1991) FK 506, rapamycin and cyclosporine A: effects on IL-4 and IL-10 mRNA levels in a T helper cell line. Transplant Proc 23:2920

    Google Scholar 

  54. Wardle E (1991) Cytokine growth factors and glomerulonephritis. Nephron 57:257

    Google Scholar 

  55. Yamamoto K, Mori A, Nakahama T, Ito M, Okudaira H, Miyamoto T (1988) Experimental treatment of autoimmune MRL/lpr/lpr mice with immunosuppressive compound FK 506. Immunology 69:222

    Google Scholar 

  56. Zeevi A, Duquesnoy R, Eiras G, Rabinowich H, Todo S, Makowka L, Starzl TE (1987) Immunosuppressive effect of FK 506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc 19 [Suppl 6]:40

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplant Institute, Division of Transplantation Medicine, and the Departments of Surgery, Medicine and Molecular Genetics and Biochemistry, University of Pittsburgh, 15213, Pittsburgh, PA, USA

    A. W. Thomson, P. B. Carroll, J. McCauley, J. Woo, K. Abu-Elmagd, T. E. Starzl & D. H. Van Thiel

Authors
  1. A. W. Thomson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. B. Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. McCauley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Woo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Abu-Elmagd
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. E. Starzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. H. Van Thiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomson, A.W., Carroll, P.B., McCauley, J. et al. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Springer Semin Immunopathol 14, 323–344 (1993). https://doi.org/10.1007/BF00192307

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00192307

Keywords

Search

Navigation